Extract
BioLineRx In-Licenses Two Additional Drug Candidates.
- Company Expands Therapeutic Pipeline to Fourteen by Signing Four In-Licensing Agreements in 2007 -
JERUSALEM, Israel -- BioLineRx Ltd. (TASE:BLRX), Israel's leading drug development company, today announced that it has signed in-license agreements to develop and commerci...See the full content of this document
Sponsored links
